focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I don't know if PF has even realised himself but in his haste to compile what is a double counting sample list of ongoing works that there he has forgotten to any alleged Middle East port security ongoing works. These came to the fore several times in the early part of 2020.
Given the glaring omission you have to ask if those ever actually existed? Or was that just being lined up as the next cash raise hype.
I didn't realise there had been 31 such fundraisers and for very little if any annual profit.
AH2021. I am sure I read somewhere in my research that if WSG need to raise for a decent airport MOU then they will need in the region of £5 million pounds. Just work out the further dilution that will come with that. I give it a year or so until the lights get switched off.
If you read through things this has just been one catastrophe after another after another and at the expense of your share price.
It needs a fundamental change of people at the top of the organisation for if it doesn't come then you will just get more of the same. It is a listed rather than a lifestyle company.
Too many getting paid too much for delivering too little. If you don't believe me sit down and work out how much money has been raised over the years and what actual profit and free cash flow WSG is delivering.
There was no appetite for YA shares and I just can't see any demand for 125 million new shares plus warrants either in any after market. That will put pressure on an already low share price on which the deep discount should already be ringing alarm bells.
Todays announcement timing also points towards a poor December trading update and you have got to be mad if you hold any shares into that update.
Whilst most other shares have been making 10 and 20% in the last week on recovery hopes and John Menzies has doubled in recent months.. Not this turkey.
Lack of director support on the low share price was your lighthouse and one that many ignored with costly result.
I really think someone needs to table some form of motion to get the CEO replaced. Perhaps the chairman also.
If not I see this ending in tears.
If you read it part of the funds was to pay for the equipment for the recently secured Palace of Westminster contract. Where did the £1 million that was left last time go?
Unfortunately the twice yearly fundraisers off hype couldn't happen what with the pandemic and lockdowns limiting air travel.
Any other listed companies CEO whose share price had fallen this far under their stewardship would do the honourable thing and resign. If not normally the largest shareholders would insist on it. Too many family members running the shop.
Merry Christmas from Pete and co.
125,000,000 new shares and warrants and a reorganisation.
Sinking ship I'm afraid and a change to nominal value has to be coming at the General meeting.
Preserve your capital and get out.
Real pleased at the vaccine approval news in the UK this morning. Four hundred thousand pounds of Covid19 stock that requires selling into a rapidly changing market place or it will also need to be "fully shelved" Along with a large section of the website promoting them....
Any current strategy on SNG should have involved shorting it. It has been the biggest evident opportunity in months. Numerous vaccines now emerging with high efficacy rates makes SNG001 redundant. Do you wait for someone to catch Covid19 and then administer SNG's therapy or instead do you vaccinate so you become immune? The answer is straightforward.
Moola
This article in the Daily Mail from yesterday talks about raising money from shareholders so that probably makes a Rights Issue part of any solution. So yes it has been talked about.
Make no mistake about it, over 6 Billion in debt is an awful lot of money and those ramping 100p numbers would do well to actually write that debtbnumber down with all its zeros and reflect on it.
*If the CVA fails then it could be admin.
*New funding will come at a price to existing holders with prime assets secured and no longer the security for ordinary shareholders.
*A RI @20p or 30p would lead to massive dilution.
For all these options to be being considered points to a real bad state of affairs.
Be very careful with your money from here on in and preservation of your capital should be key.
https://www.thisismoney.co.uk/money/markets/article-8967349/Rescue-deal-lined-Cineworld-Covid-19-leaves-struggling-6-2bn-debt.html
16th December for WW1984's release date.
A CVA is effectively a last resort deal to prevent rent creditors closing in on the company and whom it has to be said are not in any position to pay. If it fails then you are looking at the final curtain. Shorts you would expect to take full advantage of the situation.
What also will not help is the news today that WW1984 is heading for both streaming and cinema release - when Cineworlds main cinemas are closed.
Back to sub 40p.
Back to the reality of having to raise money and banking covenant tests.
Will be April before reopening and only if the studios agree to letting new releases show.
You can pick up Mulan now in Tescos for £10 so that one has made nowhere near what it was expected to make.
It is merely setting up another fall.
Astra Zenica and the Oxord vaccines results should be out next week.
With a vaccine you don't need therapeutics. About 8 vaccines all ahead of SNG001.
Be very careful about investing as recent events have shown you can lose over half in a flash listening to rampers and those wishing for an exit.
Is probably on the cards.
Had over risen and has run out of steam.
A vaccine is good news but it is highly unlikely cinemas will reopen before April.
Cine will almost certainly also have to raise further money and there must be covenant tests to come. It's always the problem with highly indebted companies.
With a vaccine now available with over a 90% success rate then you can start to visualise a cured and inoculated public and no longer any need for NCYT tests.
It's hard to visualise a business model beyond Spring Summer next year.
Expect shorters to get their teeth further into NCYT.
Vaccination v therapy.
Vaccination wins hands down and it was an easy short.
Both Pfizer and the Oxford vaccine are miles and miles ahead.
There was always a very good reason why major pharmaceutical didn't partner up and today you found out why.
Be careful with your remaining cash piles.
The Directors were not daft when they cashed in their chips.
No prizes I'm afraid for second best.